AIM ImmunoTech Inc.
AIM
$0.12
-$0.0034-2.76%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 35.00K | 50.00K | 40.00K | 65.00K | 46.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.00K | 50.00K | 40.00K | 65.00K | 46.00K |
| Cost of Revenue | 8.00K | 8.00K | 8.00K | 12.00K | 30.00K |
| Gross Profit | 27.00K | 42.00K | 32.00K | 53.00K | 16.00K |
| SG&A Expenses | 3.08M | 2.59M | 3.92M | 11.36M | 5.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.52M | 3.74M | 5.77M | 14.07M | 8.20M |
| Operating Income | -4.49M | -3.69M | -5.73M | -14.00M | -8.16M |
| Income Before Tax | -3.70M | -1.84M | -5.82M | -12.58M | -7.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.70M | -1.84M | -5.82M | -12.58M | -7.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.70M | -1.84M | -5.82M | -12.58M | -7.82M |
| EBIT | -4.49M | -3.69M | -5.73M | -14.00M | -8.16M |
| EBITDA | -4.43M | -3.63M | -5.68M | -13.95M | -8.10M |
| EPS Basic | -0.06 | -0.03 | -0.12 | -0.26 | -0.16 |
| Normalized Basic EPS | -0.04 | -0.02 | -0.07 | -0.17 | -0.10 |
| EPS Diluted | -0.06 | -0.03 | -0.12 | -0.26 | -0.16 |
| Normalized Diluted EPS | -0.04 | -0.02 | -0.07 | -0.17 | -0.10 |
| Average Basic Shares Outstanding | 57.68M | 52.84M | 49.46M | 48.89M | 48.64M |
| Average Diluted Shares Outstanding | 57.68M | 52.84M | 49.46M | 48.89M | 48.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
